Novel somatic mutations of the VHL gene in an erythropoietin‐producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells

Mutation of the VHL tumor suppressor gene is a frequent genetic event in the carcinogenesis of renal‐cell carcinoma (RCC). Circulating endothelial progenitor cells (EPCs) have important role in neoangiogenesis, and mobilization of these cells is induced by various growth factors including erythropoi...

Full description

Saved in:
Bibliographic Details
Published in:American journal of hematology Vol. 83; no. 2; pp. 155 - 158
Main Authors: Rad, Farhad Haghighi, Ulusakarya, Ayhan, Gad, Sophie, Sibony, Mathilde, Juin, Fabrice, Richard, Stéphane, Machover, David, Uzan, Georges
Format: Journal Article
Language:English
Published: Hoboken Wiley Subscription Services, Inc., A Wiley Company 01-02-2008
Wiley-Liss
Wiley
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Mutation of the VHL tumor suppressor gene is a frequent genetic event in the carcinogenesis of renal‐cell carcinoma (RCC). Circulating endothelial progenitor cells (EPCs) have important role in neoangiogenesis, and mobilization of these cells is induced by various growth factors including erythropoietin (EPO). With this regard, we analyzed a patient with EPO‐producing clear‐cell RCC and polycythemia. DNA extraction and sequencing analysis of the VHL gene were performed from the tumor and the adjacent normal renal tissue. Isolated and cultured circulating EPCs from the blood taken with phlebotomy were characterized by flow cytometry and immunofluorescence analysis. This RCC had two novel somatic mutations of the VHL gene, p.Leu128Pro and p.Asn131Lys. Culture of blood mononuclear cells revealed a strikingly high number of endothelial cell colonies derived from EPCs (nearly 10‐fold more than in controls). Elevated number of circulating EPCs seems to be related to high EPO production from RCC with novel double somatic mutation of the VHL gene in this patient. Am. J. Hematol., 2008. © 2007 Wiley‐Liss, Inc.
Bibliography:F.H.R. and A.U. contributed equally to this work.
ISSN:0361-8609
1096-8652
DOI:10.1002/ajh.21019